$13.37
Targeted Therapy – Bruton’s Tyrosine Kinase (BTK) Inhibitor
Ibrunat 140mg Capsule is a prescription medicine used in the treatment of certain blood cancers, including mantle-cell lymphoma and chronic lymphocytic leukemia (CLL). It is often prescribed in CLL patients who have received at least one prior therapy.
The dose and duration are determined by your doctor based on your condition and response. Your doctor may order regular blood tests to monitor your blood cell counts during treatment.
Ibrunat (Ibrutinib) is prescribed for:
Research is ongoing into Ibrutinib’s role in other lymphomas and autoimmune conditions, but these are not standard uses.
This medicine increases your risk of bleeding. Report unusual bruising, nosebleeds, blood in urine/stool, or prolonged bleeding to your doctor immediately. Seek emergency help for uncontrolled or severe bleeding.
This medicine may cause abnormal heart rhythms (atrial fibrillation, QT prolongation), which can be serious.
This medicine may cause serious harm to an unborn baby, including birth defects or pregnancy loss.
Common side effects include:
Seek medical help immediately if you develop:















